Assenagon Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Hold |
6,172
| – | – | ﹤0.01% | 1090 |
|
|
2025
Q1 | $243K | Sell |
6,172
-96,908
| -94% | -$3.82M | ﹤0.01% | 1074 |
|
|
2024
Q4 | $3.1M | Sell |
103,080
-67,154
| -39% | -$2.02M | 0.01% | 795 |
|
|
2024
Q3 | $3.98M | Sell |
170,234
-318,709
| -65% | -$7.45M | 0.01% | 749 |
|
|
2024
Q2 | $8.7M | Buy |
+488,943
| New | +$8.7M | 0.02% | 448 |
|
|
2023
Q4 | – | Sell |
-145,846
| Closed | -$1.22M | – | 1439 |
|
|
2023
Q3 | $1.22M | Buy |
+145,846
| New | +$1.22M | ﹤0.01% | 971 |
|
|
2023
Q2 | – | Sell |
-230,602
| Closed | -$3.47M | – | 1417 |
|
|
2023
Q1 | $3.47M | Buy |
+230,602
| New | +$3.47M | 0.01% | 652 |
|
|
2022
Q3 | – | Sell |
-2,088,952
| Closed | -$8.88M | – | 1492 |
|
|
2022
Q2 | $8.88M | Buy |
2,088,952
+1,834,924
| +722% | +$7.8M | 0.03% | 375 |
|
|
2022
Q1 | $2.42M | Buy |
254,028
+92,349
| +57% | +$878K | 0.01% | 731 |
|
|
2021
Q4 | $3.07M | Buy |
+161,679
| New | +$3.07M | 0.01% | 643 |
|
|
2021
Q3 | – | Sell |
-152,823
| Closed | -$5.93M | – | 1386 |
|
|
2021
Q2 | $5.93M | Sell |
152,823
-3,424
| -2% | -$133K | 0.02% | 413 |
|
|
2021
Q1 | $7.53M | Buy |
+156,247
| New | +$7.53M | 0.03% | 374 |
|
|
2019
Q1 | – | Sell |
-156,700
| Closed | -$642K | – | 1071 |
|
|
2018
Q4 | $642K | Buy |
+156,700
| New | +$642K | 0.01% | 719 |
|